Mirati Therapeutics, Inc. Operating Income 2013-2023 | MRTX
Mirati Therapeutics, Inc. operating income from 2013 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Mirati Therapeutics, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2022 | $-760 |
| 2021 | $-573 |
| 2020 | $-369 |
| 2019 | $-222 |
| 2018 | $-103 |
| 2017 | $-72 |
| 2016 | $-84 |
| 2015 | $-65 |
| 2014 | $-39 |
| 2013 | $-32 |
| 2012 | $-20 |
| 2011 | $-10 |
| Mirati Therapeutics, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-172 |
| 2023-06-30 | $-187 |
| 2023-03-31 | $-194 |
| 2022-12-31 | $-212 |
| 2022-09-30 | $-186 |
| 2022-06-30 | $-177 |
| 2022-03-31 | $-184 |
| 2021-12-31 | $-197 |
| 2021-09-30 | $-79 |
| 2021-06-30 | $-164 |
| 2021-03-31 | $-132 |
| 2020-12-31 | $-106 |
| 2020-09-30 | $-89 |
| 2020-06-30 | $-85 |
| 2020-03-31 | $-89 |
| 2019-12-31 | $-75 |
| 2019-09-30 | $-57 |
| 2019-06-30 | $-48 |
| 2019-03-31 | $-43 |
| 2018-12-31 | $-30 |
| 2018-09-30 | $-29 |
| 2018-06-30 | $-29 |
| 2018-03-31 | $-15 |
| 2017-12-31 | $-18 |
| 2017-09-30 | $-17 |
| 2017-06-30 | $-19 |
| 2017-03-31 | $-18 |
| 2016-12-31 | $-20 |
| 2016-09-30 | $-20 |
| 2016-06-30 | $-22 |
| 2016-03-31 | $-22 |
| 2015-12-31 | $-18 |
| 2015-09-30 | $-19 |
| 2015-06-30 | $-16 |
| 2015-03-31 | $-12 |
| 2014-12-31 | $-10 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $-10 |
| 2014-03-31 | $-8 |
| 2013-12-31 | $-8 |
| 2013-09-30 | $-9 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $-8 |
| 2012-12-31 | $-6 |
| 2012-09-30 | $-6 |
| 2012-06-30 | $-5 |
| 2012-03-31 | $-3 |
